Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNS020QD (Fentanyl 1-Day Patch) in PHN, CRPS, or Postoperative Pain
NCT01008553Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in postherpetic neuralgia (PHN), complex regional pain syndrome (CRPS), postoperative pain, sponsored by Janssen Pharmaceutical. Started Dec 2008; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
postherpetic neuralgia (PHN)complex regional pain syndrome (CRPS)postoperative pain
Beyond the preview
Go deeper on NCT01008553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008553.